EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 276.1 ILa | +0.40% |
|
+3.18% | -7.91% |
| 05-23 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| 05-23 | Evogene Ltd. Provides Revenue Guidance for the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 37.58M | - | - | - | |||
| 56.69B | - | |||||
| 41B | ||||||
| 38.11B | ||||||
| 26.89B | ||||||
| 25.59B |
- Stock Market
- Equities
- EVGN Stock
- Charts Evogene Ltd.
- Sector Chart
